Watchlist
Dow 26,405.76 158.80 0.61%
S&P 500 2,907.95 3.64 0.13%
Nasdaq 7,950.04 -6.07 -0.08%
GlobalDow 3,113.10 1.90 0.06%
Gold 1,208.50 0.20 0.02%
Oil 71.64 0.52 0.73%
TLRYUSAfter HoursBack To Top
Last Updated: Sep 19, 2018 7:59 p.m. EDT Delayed quote

$ 200.30

-13.76 -6.43%
After Hours Volume: 1.4M
Close Chg Chg %
$214.06 59.08 38.12% 59.08 38.12%
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
376.3% vs Avg.
Volume: 30.3M 65 Day Avg. - 8.1M
Open: 233.58
Close: 214.06
151.40 Day Low/High 300.00
Day Range
20.10 52 Week Low/High 300.00

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $233.58
  • Day Range 151.40 - 300.00
  • 52 Week Range 20.10 - 300.00
  • Market Cap $14.44B
  • Shares Outstanding 76.48M
  • Public Float 17.81M
  • Beta -4.96
  • Rev. per Employee $83.83K
  • P/E Ratio n/a
  • EPS n/a
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest 3.5M 08/31/18
  • % of Float Shorted 19.65%
  • Average Volume 8.06M

Performance

5 Day
  • 78.74%
1 Month
  • 459.63%
3 Month n/a
YTD n/a
1 Year n/a

Recent News

  • MarketWatch
  • Other Dow Jones
U.S. stocks close mostly higher as investors take escalating trade tensions in stride

U.S. stocks close mostly higher as investors take escalating trade tensions in stride

Breaking

Dow ends session within 0.8% of January record as 10-year government bond yields hit 4-month high

U.S. stocks on Wednesday ended mostly higher, with the Dow Jones Industrial Average and the S&P 500 index ending within a stone's throw of a fresh record as investors shook off U.S.-China trade-war worries. The Dow rose about 160 points, or 0.6%, at 24,406, closing within 0.8% of its Jan. 26 all-time record at 26,616.71. The S&P 500 index , meanwhile, closed up 0.1% at 2,907, not far from its all-time peak above 2,914. The Nasdaq Composite Index , however, lagged behind its peers, closing about 0.1% lower at 7,950. A rise in yields for the 10-year Treasury note to its highest level since May around 3.08%, helped to lift shares of financial companies, which enjoyed the best performance on the day among the 11 sectors of the S&P 500. A popular fund used to bet on the financials sector, the Financial Select Sector SPDR ETF , rose by 1.8%, representing the best daily gain since July 9. In corporate news, Wall Street focused on shares of Tilray Inc. , which surged in an extremely volatile day, after the U.S. Drug Enforcement Administration signed off on a plan for the company to import a marijuana product to test its effectiveness in treating a disorder that affects millions of Americans. On Wednesday, the stock was halted multiple times after surging by 94% before ending up 38%. The stock has been a trading favorite this past month as investors bet that stocks related to marijuana could see massive growth. Tilray has surged more than 600% over the past month.

Breaking

Tilray stock halted several times amid rollercoaster final hour of trading

Tilray Inc. shares were halted five times in a span of less than an hour as Wednesday's trading session neared a close, with shares zooming between brief small losses and incredibly large gains. Tilray stock was flying high Wednesday, hitting an intraday record high of $300 a share -- a daily gain of 94% that added to a an increase of more than 400% in the past month. However, when shares were halted for a fourth time in less than 40 minutes at 3:33 p.m. Eastern time, they were trading at $168.33, a daily gain of just 8.6%. When they resumed trading at 3:43 p.m. Eastern, shares clawed back to gains of 40% before being halted with about 10 minutes to go in the session. Shares were allowed to begin trading yet again at almost the exact moment the market closed, and recorded a final price in the regular session of $214.06, up 38.1% on the day. The cannabis producer went public in July at $17 a share, and traded in a range from $151.40 to $300 Wednesday after closing at $154.98 Tuesday. In the first few minutes of after-hours trading, shares dropped more than 10%.

Tilray halted yet again

Tilray halted yet again

Why Americans pay more for cannabis than Canadians

Why Americans pay more for cannabis than Canadians

Tilray stock paused for volatility for a fourth time

Tilray stock paused for volatility for a fourth time

Tilray resumes trading for a third time

Tilray resumes trading for a third time

Tilray stock paused for a third time in less than 30 minutes

Tilray stock paused for a third time in less than 30 minutes

Tilray is the poster boy of short-squeeze stock candidates — here’s how to find others

Tilray is the poster boy of short-squeeze stock candidates — here’s how to find others

Tilray shares halted for volatility, restarted, and paused again in past 15 minutes

Tilray shares halted for volatility, restarted, and paused again in past 15 minutes

Reefer madness: Tilray’s mind-bending move lights up the internet

Reefer madness: Tilray’s mind-bending move lights up the internet

Want to invest in cannabis companies? Watch out for rogue players

Want to invest in cannabis companies? Watch out for rogue players

UPDATE: Tilray stock soars another 38%

Shares of Canadian cannabis company Tilray Inc. soared another 38% Wednesday, extending their recent gains as excitement builds ahead of full legalization of marijuana in Canada on Oct. 17. The stock has gained almost 600% in the last month, swept up in a broader rally among weed stocks. Tilray Chief Executive Brendan Kennedy told CNBC late Tuesday that cannabis is a "great hedge" for alcohol and drug companies, which have been sniffing around the sector. Cronos Group Inc. was up 9% premarket and Canopy Growth Corp. was up 5%. S&P 500 futures were down slightly. The S&P 500 has gained about 2% in the last month, while the Dow Jones Industrial Average has gained 2.2%.

Get ready for U.S. stocks to come off their ‘sugar high’: JPM strategists

Get ready for U.S. stocks to come off their ‘sugar high’: JPM strategists

As Tilray soars, short sellers keep betting against pot stocks

As Tilray soars, short sellers keep betting against pot stocks

Tilray leads cannabis stocks higher as sector continues to rally

Tilray leads cannabis stocks higher as sector continues to rally

Tilray's stock soars 18% premarket, after rocketing 29% on Tuesday

Tilray's stock soars 18% premarket, after rocketing 29% on Tuesday

Tilray stock rises 29% on plans to import cannabis to U.S. for clinical trial

Tilray stock rises 29% on plans to import cannabis to U.S. for clinical trial

Enjoy Coke — and the money it might make for marijuana investors

Enjoy Coke — and the money it might make for marijuana investors

Trade war’s ‘nuclear option’ could be bad for Apple, Amazon: strategist

Trade war’s ‘nuclear option’ could be bad for Apple, Amazon: strategist

Marijuana Stocks Just Keep Soaring Higher. But Even the Bulls See a Bubble

Marijuana stocks are riding a wave of giddy news, with a rally by Tilray reaching a point of absolute hysteria. But don’t get too high on all these surging pot stocks.

  • on Barron's Online

Marijuana Stock Highs Are Squeezing Short Sellers. But They’re Still Betting on a Bust

Investors shorting stocks related to the cannabis industry have lost $490 million on paper this year, but bets that pot stocks will fall have only increased despite high costs as the sector has rallied.

  • on Barron's Online

Stocks to Watch: Facebook, Alphabet, Viking Therapeutics, FedEx

Here are some of the companies with shares expected to trade actively in Tuesday’s session.

  • on The Wall Street Journal

Marijuana Stocks Dropped After Some Troubling News for Canadian Pot Investors

Cannabis-related stocks dropped in after-hours trading following a report that the U.S. may bar Canadians who invest in the companies from entering the U.S.

  • on Barron's Online

Marijuana Stocks Just Had a Selloff, and There’s Only One Bright Spot

A Canadian cannabis company was the sole bright spot in the sector on Wednesday, with most stocks falling as investors digested news of a possible U.S. regulatory ban on flavored e-cigarettes.

  • on Barron's Online

Marijuana Company Is Pressed to Make Deal by Activist Investor

Hexo has drawn interest from activist investor Riposte Capital, which fears the Canadian medical-marijuana maker will miss out on a frenzy of deal making in the budding industry.

  • on The Wall Street Journal

Stocks to Watch: Dell Technologies, Amazon.com, Facebook, CVS Health, Lands’ End, CBS, American Express, Cushman & Wakefield, DocuSign, Tilray, Cloudera

Here are some of the companies with shares expected to trade actively in Thursday’s session.

  • on The Wall Street Journal

Marijuana Stocks Are Rallying Again as Pot Companies Get Partners

Companies stand to gain as Canada follows trends seen in those U.S. states where recreational cannabis has been legalized.

  • on Barron's Online

Pot Stocks Can’t Be Ignored

Marijuana stocks have been an investor darling this year, with even hedge fund billionaire Leon Cooperman betting his own money in the sector.

  • on Barron's Online

Marijuana Stocks Just Keep Going Higher: ‘This Is Like Bitcoin Levels’

Tilray and Cronos continue to rally, as a cannabis investor calls the market “completely irrational.”

  • on Barron's Online

Booze Companies, Just Say ‘No’

Alcoholic-beverage companies are getting into marijuana, giving that sector a big boost, but their own share prices haven’t benefited.

  • on The Wall Street Journal

Recent News

  • Other News
  • Press Releases

Tilray Shares Halted 5 Times In Wild Trading Day

The company's shares surged 93%, traded in the red and saw multiple trading halts, all in one day.

  • on Investopedia.com

Dow Jones Closes at 26,405.76 on Wednesday

Dow Jones Closes at 26,405.76 on Wednesday

  • on GuruFocus.com

What Happened in the Stock Market Today

  • on Motley Fool

Tilray Is Partying Like It's 1999 (and It Won't End Well)

  • on Motley Fool

Tilray Soars ~60% on September 19—What Drove the Stock Up?

Cannabis stock Tilray (TLRY) soared to a new high of $253.80, up ~60% on September 19. TLRY has risen ~1,390% above its IPO price of $17.00.

  • on MarketRealist.com

5 Top Stock Trades for Thursday — Trading FANG Stocks and Tilray

5 Top Stock Trades for Thursday — Trading FANG Stocks and Tilray

  • on InvestorPlace.com

This Marijuana Stock Picked a Good Day to Top the News Cycle

  • on Motley Fool

Tilray's wild ride includes three halts, "down" to +8.6%

Tilray's wild ride includes three halts, "down" to +8.6%

  • on Seeking Alpha

Here's Why Cronos Group Inc. Is Crushing It Again Today

  • on Motley Fool

Peter Thiel-Backed PE Fund's Tilray Stake Soars to $12B

Since its IPO in July 2018, Tilray shares have soared more than 1,300%.

  • on Investopedia.com

Why Tilray Stock Is Bound to Fall Hard Sooner or Later

Why Tilray Stock Is Bound to Fall Hard Sooner or Later

  • on InvestorPlace.com

The Options Market Suggests Tilray's Huge Gains Might Not Last Long

The Options Market Suggests Tilray's Huge Gains Might Not Last Long

  • on benzinga.com

The Options Market Suggests Tilray's Huge Gains Might Not Last Long

The Options Market Suggests Tilray's Huge Gains Might Not Last Long

  • on benzinga.com

Why Tilray, Inc. Stock Is Skyrocketing Higher Again Today

  • on Motley Fool

The 1 Thing Every Marijuana Investor Needs to Know

  • on Motley Fool

Cannabis Is A Short: Tilray Has 73% Downside To My $40 Price Target

Cannabis Is A Short: Tilray Has 73% Downside To My $40 Price Target

  • on Seeking Alpha

Would a New Marijuana Tax Crush Canada's Pot Stocks?

  • on Motley Fool

It's Not All Negative News - Cramer's Mad Money (9/18/18)

It's Not All Negative News - Cramer's Mad Money (9/18/18)

  • on Seeking Alpha

Tilray Pushes Deeper Into Healthcare

  • on Motley Fool

Tilray May Reach $100B Valuation, Says CEO

Brendan Kennedy added that alcohol and pharma companies would be fools not to invest in the cannabis sector.

  • on Investopedia.com

United States to Issue Additional Cannabis Growing Licenses for Research Purposes

United States to Issue Additional Cannabis Growing Licenses for Research Purposes

  • on PR Newswire - PRF

Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected

Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected

  • on PR Newswire - PRF

CBD Contributes to Continued Growth for Nutraceutical, Pharmaceutical and Cannabis Key Players

CBD Contributes to Continued Growth for Nutraceutical, Pharmaceutical and Cannabis Key Players

  • on PR Newswire - PRF

Canadian Cannabis Stocks Flying Higher on Monday

Canadian Cannabis Stocks Flying Higher on Monday

  • on ACCESSWIRE

Venture Breakfast Bits, by 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

  • on 247MarketNews

Namaste Signs Cannabis Purchase Agreement With Tilrayœ

Namaste Signs Cannabis Purchase Agreement With Tilrayœ

  • on PR Newswire - PRF

Global Cannabis Market Set to Expand as Investment Traffic Increases

Global Cannabis Market Set to Expand as Investment Traffic Increases

  • on PR Newswire - PRF

Global Cannabis Market Slated to Expand With Greater Investor Interest

Global Cannabis Market Slated to Expand With Greater Investor Interest

  • on PR Newswire - PRF

NetworkNewsBreaks - The Flowr Corp. Prepares to Join the Growing Ranks of Publicly Traded Cannabis Companies

NetworkNewsBreaks - The Flowr Corp. Prepares to Join the Growing Ranks of Publicly Traded Cannabis Companies

  • on NetworkNewsWire

Hemp and Cannabidiol (CBD) Benefits Pushing Consumer Demand to New Highs in Projected Billion Dollar Industry

Hemp and Cannabidiol (CBD) Benefits Pushing Consumer Demand to New Highs in Projected Billion Dollar Industry

  • on PR Newswire - PRF

Data Shows the Cannabis Industry Could Create Over 467,000 Jobs by 2022

Data Shows the Cannabis Industry Could Create Over 467,000 Jobs by 2022

  • on PR Newswire - PRF

Big Opportunities for Cannabis Producers Prevail in Ever Growing Market

Big Opportunities for Cannabis Producers Prevail in Ever Growing Market

  • on PR Newswire - PRF

Biotech and Cannabis Firms to Watch as Acquisition, Investment, and Licensing Season Begins

Biotech and Cannabis Firms to Watch as Acquisition, Investment, and Licensing Season Begins

  • on PR Newswire - PRF

Cannabis Industry Growth Unperturbed by Federal Pushback

Cannabis Industry Growth Unperturbed by Federal Pushback

  • on PR Newswire - PRF

Data Shows Global Cannabis Market Could Eclipse USD 30 Billion by 2021

Data Shows Global Cannabis Market Could Eclipse USD 30 Billion by 2021

  • on PR Newswire - PRF

3 Cannabis Stocks to Watch Ahead of Canada's Legalization

3 Cannabis Stocks to Watch Ahead of Canada's Legalization

  • on ACCESSWIRE

Cannabis Mergers, Acquisitions, and IPOs

Cannabis Mergers, Acquisitions, and IPOs

  • on PR Newswire - PRF

Tilray Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Tilray Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

  • on BusinessWire - BZX

Tilray Inc. Cl 2

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. (See Full Profile)

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4 Full Ratings

How Cannabis Stocks Have Performed Recently

  • on MarketRealist.com

What Analysts Recommend for Cronos Group

  • on MarketRealist.com

What Do Analysts Think about Scotts Miracle-Gro?

  • on MarketRealist.com

Partner Content